NEUROLOGY AND MEDICINE Neurology and the liver
نویسندگان
چکیده
Neurological syndromes commonly occur in patients with liver disease. A neurological syndrome associated with a liver disease may be a complication of the disease, it may be induced by a factor that also contributes to the disease—for example, alcohol—or it may have no relation to the presence of the liver disease. Neurological deficits associated with liver disease may aVect the CNS, the peripheral nervous system, or both. This review focuses on syndromes characterised by altered CNS function associated with structural liver diseases. Space does not permit consideration of peripheral neuropathies associated with liver disease (for example, xanthomatous peripheral neuropathy), diseases of childhood that aVect the liver and CNS (for example, Reye’s syndrome), or neurological consequences of hepatic lesions characterised by specific enzyme deficiencies (for example, congenital hyperammonaemias, the porphyrias, kernicterus, galactosaemia, and Zellweger’s syndrome (cerebrohepatorenal syndrome)). That there is a relationship between the functional status of the liver and that of the brain has been known for centuries. The most widely recognised aspect of this relation is that hepatocellular failure may be complicated by the behavioural syndrome of hepatic encephalopathy, in which neurotransmission in the brain is altered. 3 Recently, it has been suggested that two other behavioural complications of liver disease, scratching due to pruritus in cholestatic patients 5 and profound fatigue in patients with chronic cholestasis, 7 may also be associated with altered neurotransmission in the brain.
منابع مشابه
Evaluation of Liver Enzymes Rising in Patients Treated with Sodium Valproate (VPA)
Introduction Valproic acid (VPA, Valproate) is an eight-branch fatty acid and varies from other antiepileptic drugs. VPA use might lead to mild to severe hepatotoxicity. The aim of this study was to investigate valproic acid impact on liver transaminases at the beginning of VPA treatment and after three and six months of it. Materials and Methods This study was designed as a cross sectional pro...
متن کاملCerebral Venous-Sinus Thrombosis: Risk Factors, Clinical Report, and Outcome. A Prospective Study in the North East of Iran
Introduction: Cerebral venous-sinus thrombosis (CVST) is a life threatening condition that needs rapid diagnosis and treatment. It appears comparatively more common in Middle East and South Asia. Objectives: To determine the demographic, clinical patterns, etiologies and prognostic factors of CVST in the North East of Iran. Materials and Methods: All adult patients admitted with a documented di...
متن کاملP38: The Immunoregulatory Effect of Cyclic Dinucleotides on Human Immune Cells
In multiple sclerosis (MS) beneficial effects have been assigned to the interferon (IFN)-I subclass IFN-ß, making its administration a first-line disease-modifying treatment in MS. IFN-I responses can be induced by cyclic-dinucleotide (CDN) triggered activation of Stimulator-of-interferon-genes (STING) and have essential immunomodulatory effects. A beneficial effect of STING activation on...
متن کاملA Treatable Refractory Epilepsy: A Case Report
Introduction Biotinidase deficiency is a life threatening inborn error of metabolism specially when delayed in diagnosis. We report a 2-month-old male infant that presented with refractory infantile spasm, alopecia and seborrheic dermatitis. With a high suspicion of the biotinidase deficiency we started biotin 10 mg daily orally before definite diagnosis was made. Rapid treatment was life-savin...
متن کاملSafety and Efficacy of Fingolimod in Iranian Patients with Relapsing-remitting Multiple Sclerosis
Introduction: Fingolimod is the first confirmed oral immune-modulator to treat Relapsing-Remitting Multiple Sclerosis (RRMS). This study aimed to investigate the safety and efficacy of fingolimod therapy in Iranian patients with RRMS. Methods: In our trial, 50 patients resistant to conventional interferon therapy were assigned to receive fingolimod 0.5 mg per day for 12 months. The number of D...
متن کاملPeripheral Neuro Electrodiagnostic Abnormalities in Patients with Multiple Sclerosis: A Cross Sectional Study
Background: Multiple sclerosis (MS) is known to affect essentially the central nervous system; however, peripheral nerve involvement, as an additional cause of disability, has been recently noticed. Objectives: This study was aimed to perform detailed electrodiagnostic assessments in MS patients to evaluate peripheral nervous system involvement. Materials and Methods: A total of eighty MS...
متن کامل